Biomedical engineers at Cornell University are turning sticky nanoparticles into “cancer-killing machines” to prevent cancer cells from spreading throughout the body. The groundbreaking research could one day pave the way for eliminating 90 percent of cancer deaths. Full article in Cornell Chronicle
Ph.D. student Omary Mzava is developing cell-free nucleic acids assays to diagnose and monitor infectious and immune-related diseases. Read more about From Tanzania to Cornell: A biomedical engineer's journey to bridge gaps in global health
From a research focus to an entrepreneurial mindset, Ph.D. student Jon Albo is developing new technology to revolutionize how experiments are done, enabling better treatment of illness in humans and animals Read more about Revolutionizing Research: A drive for real-world impact results in cutting-edge technology
Research, service and giving back are at the heart of Peyton Lancaster's Cornell experience. Read more about Paying it forward: A heart patient inspired to impact future patients
